REASON: TKI sensitive EGFR mutation status and associated characteristics of advanced NSCLC patients – Results from a German registry.

Thomas, M., Eberhardt, W., Graf von der Schluenburg, J., Dietel, M., Schirmacher, P., Gutendirf, B., Schaller, F., Schütte, W., 2011.

Onkologie 34 (suppl 6)(V451), 124.

Studie: REASON; Indikation: Bronchialkarzinom; Jahr: 2011; Veranstaltung: DGHO; Journal: Onkologie

iOMEDICO AG
Ellen-Gottlieb-Straße 19
79106 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com